The global reinsurers’ outlook promising but uncertain. The global reinsurance market is expected to grow modestly, with the most substantial growth predicted for the Asia-Pacific and Latin America regions, according to Munich Re. The market for alternative risk transfer adjusted for higher equity effects from interest rates is also expected to rebound to $461bn in 2023 from $434bn in 2022. Investing in risk modeling and high-definition models, as well as harnessing data and technology are priorities.
The True Cost of Focusing on Cost Instead of Cost-Effectiveness
When payors consider only the cost of the medication and not the cost and risk to the patient, doctor, and healthcare system, the irony is
